Several types of vaccine trials are underway in India for the prevention of corona vaccine. In this series, the second corona vaccine in India has now been approved for human testing.
In a statement from the company, the vaccine has been found to be immunogenic to many species of animals. Antibodies made in animal studies have been able to completely neutralize wild-type viruses.
The company plans to start a human clinical trial in July 2020 in view of the prevention of corona virus. The global pharmaceutical company Zydus has announced that its plasmid DNA vaccine candidate (Zykov-D) for Kovid-19 has developed entirely in the country.
The company has developed the vaccine at its Vaccine Technology Center in Ahmedabad. It has now received permission from the Drug Controller General of India (DCGI) and the Central Drugs Standard Control Organization (CDSCO) to start human clinical trials of Phase 1 / Phase 2. The company has expressed the possibility that this vaccine will work to a great extent.